Zhu Z, Ni J, Cai X, Su S, Zhuang H, Yang Z, Chen M, Ma S, Xie C, Xu Y, Li J, Ge H, Liu A, Zhao L, Rao C, Xie C, Bi N, Hui Z, Zhu G, Yuan Z, Wang J, Zhao L, Zhou W, Rim CH, Navarro-Martin A, Vanneste BGL, Ruysscher D, Choi JI, Jassem J, Chang JY, Kepka L, Käsmann L, Milano MT, Van Houtte P, Suwinski R, Traverso A, Doi H, Suh YG, Noël G, Tomita N, Kowalchuk RO, Sio TT, Li B, Lu B, Fu X. International consensus on radiotherapy in metastatic non-small cell lung cancer. Transl Lung Cancer Res. 2022 Sep;11(9):1763-1795. doi: 10.21037/tlcr-22-644. PMID: 36248338; PMCID: PMC9554677.
International consensus on radiotherapy in metastatic non-small cell lung cancer - PubMed
肺癌是全世界癌症相关死亡的主要原因,大多数病例为非小细胞肺癌(NSCLC)。以往放疗被用作转移性NSCLC的挽救性治疗,但随着自身技术的大量进步和前沿治疗药物的发展,如靶向治疗和免疫检查点抑制剂(ICIs),放疗在疾病多学科管理中越来越重要。
|
|